At Nephron Research, our mission is to be essential to our clients’ investment process.
As the market’s leading independent healthcare equity research provider, we strive to separate market noise from the insights that are essential to the investment process.
Nephron’s primary differentiators lie in our research teams and their approach to equity research. The deep experience and insight of our analysts as well as an intense drive to serve a discerning client base sets us apart. With the sole focus of creating value for clients, Nephron can provide a depth of coverage, breadth of access, and consultative services that traditional models lack.
Delivered via an independent and unbiased subscription-only model, Nephron is directly aligned with our client’s interests and investment processes
Meet The Team
At Nephron Research, our experience and connectivity drive deep research products which is supplemented by hyper-relevant corporate access
Process Drives We tackle the most important debates, react quickly, and provide leading perspective
LillyDirect Highlights Opportunity for Pharma, Shortcomings of Pharma Supply Chain
Download
OB/GYN Survey: NTRA Builds Lead, Views on USPSTF Cervical Screening for HOLX
Download
Next Big Things: Why Pulsed Field Ablation Will Revolutionize the Treatment of AF
Download
Alzheimer’s – A Large, Untapped Dx & Bioprocessing Opp w/ a Lot of Unknowns
DownloadNephron Research Curates Dozens of Events Each Year Designed for Maximum Impact to Client Investment Process
This April, Nephron Research will host NephronNext, a series of virtual presentations and 1x1 meetings with a curated group of private company innovators and disruptors selected for their potential to transform healthcare and their relevance to both public and private investors.
The 2024 Nephron Pharmacy & PBM Innovation Symposium will center on challenges to traditional Pharmacy and PBM business practices with a specific focus on new reimbursement models (i.e.: cost+), new direct-to-consumer pharmacy models (i.e.: LillyDirect), new PBM technologies (i.e.: modern platforms and consumer experiences) and new regulatory and legal threats (i.e.: FTC, legislation and ERISA law suits).
This Fall, Nephron Research will once again bring together the finest minds in healthcare to dissect the industry’s most important trends and debate emergent themes in the heart of Napa Valley.
Our independent model and deep healthcare and investment expertise allows us to deliver a full suite of bespoke
and consultative services to investment firms and market participants.
